What this means
This is a planned study that has not started enrolling people yet. It has no results, so it cannot show whether the serum helps.
Plain-English summary written by an AI model from the registry listing.
- Status
- Opening soon
- Who can join
- Ages 30–70 · Not yet tested; planned study of adults in Buenos Aires, Argentina
- Where
- Not listed
The science
- Registered title
- Evaluation of Efficacy and Tolerabilty of MelaB3 Serum in Combination of 35% Glycolic Acid Peeling Compared to 35% Glycolic Acid Peeling Alone in Various Hyperpigmentation Conditions
- Trial ID
- NCT07429786 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Hyperpigmentation, Melasma, Solar Lentigo, Peeling
- What is tested
- Glycolic acid peel alone, MelaB3 serum
- Sponsor
- Cosmetique Active International
- Ages
- 30 Years to 70 Years
- Dates
- First posted Feb 24, 2026 · updated Feb 24, 2026
Registry summary
Randomized clinical trial to assess the effectiveness and tolerability of Mela B3 serum in combination with 35% glycolic acid peel vs. 35% glycolic acid peel for the treatment of various hyperpigmentation conditions (melasma, post-inflammatory hyperpigmentation and solar lentigo) and signs of aging in a population of participants from the Autonomous City of Buenos Aires, Argentina.